https://www.thebodypro.com/category/adverse-events-comorbidities-hiv/tag/lipodystrophy-body-fat

The Latest

Promo Image

Metabolic Complications Myths

Introduction Myth #1: Protease inhibitors are responsible for the increases in belly fat. Myth #2: People who get bigger bellies on HIV meds typically also lose fat in their arms and legs. Myth #3: Loss of limb fat during HIV therapy only occ...

Promo Image

BMI Chart

To determine your BMI (body mass index):

Find your height on the side (in metres on the left and in feet on the right) and draw a horizontal line across the chart. Find your weight (in kilograms across the bottom of in pounds across the top) and d...

Promo Image

Protein Accumulation Might Cause Fat Deposits, Other Side Effects in HIV-Positive People Taking Protease Inhibitors, Study Says

Similarities between genetic conditions that cause early aging and side effects experienced by some HIV-positive people when taking protease inhibitors might explain the fat accumulation associated with the drugs, according to a study published Monda...

Promo Image

Drug Watch: TH9507 -- An Experimental Treatment for Lipodystrophy

Introduction Lipodystrophy Treating Lipodystrophy with Growth Hormone Products TH9507: A New Treatment Option? Conclusion Selected Sources

Introduction

As the use of highly active antiretroviral therapy (HAART) became widespread, HIV po...

Promo Image

An Interview With Steven Grinspoon, M.D.

Listen (1.3MB MP3, 3 min.)

Dr. Steven Grinspoon, of Massachusetts General Hospital in Boston, presented the results of a large trial looking at the effects of TH9507, a growth hormone releasing factor analog, on HIV-associated abdominal fat accumul...

Promo Image

Steven Grinspoon, M.D., Study Summary and Press Conference

Listen (5MB MP3, 12 min.)

Dr. Steven Grinspoon, of Massachusetts General Hospital in Boston, presented the results of a large trial looking at the effects of TH9507, a growth hormone releasing factor analog, on HIV-associated abdominal fat accumula...

Promo Image

Comparing the Effects of Rosiglitazone, Pravastatin, Recombinant Human Growth Hormone and Combinations Thereof on HIV-Associated Lipodystrophy

Metabolic and morphologic manifestations of HIV and antiretroviral therapy are becoming increasingly common. The physical changes associated with fat loss (lipoatrophy) and fat accumulation (lipohypertrophy) are particularly troublesome for patients....

Promo Image

Metabolic Complications of HIV Therapy

Introduction HIV-Associated Lipodystrophy Insulin Resistance Dyslipidemia Hyperlactatemia and Lactic Acidosis Bone Disease References

Introduction

The use of effective antiretroviral therapy (ART) has resulted in tremendous improvemen...

Promo Image

Initiation of HAART May Increase Free Testosterone Levels and Fat-Free Mass

Background

Probably the most common endocrine abnormality seen in men with HIV is hypogonadism (or low testosterone levels). Symptoms may include fatigue, weight loss, muscle mass loss, depression and low libido. This problem sometimes goes undiagno...

Promo Image

Metabolic Complications at the XVI International AIDS Conference: Part 1 -- An Overview of New Data

For Part 2 of this report, click here.

The International AIDS Conference, formerly known as the World AIDS Conference, was at one time the premier venue for the presentation of new data related to the pathogenesis, epidemiology, prevention and treat...